Physician profile
James D Bennett
NPI 1871596130
$3,528.70
in general payments reported to CMS, 2019-2025
18 companies · $748 in 2025
The $748 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $204 · 2021: $983 · 2022: $566 · 2023: $326 · 2024: $526 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $911.78 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| New World Medical,INC. | $454.38 | 2022-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Johnson & Johnson Surgical Vision, INC. | $446.26 | 2020-2025 | Tecnis Simplicity |
| Glaukos Corporation | $311.92 | 2021-2025 | Photrexa Viscous and Photrexa |
| Ocular Therapeutix, INC. | $275.50 | 2020-2025 | Dextenza |
| Abbvie INC. | $250.12 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $165.35 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $117.00 | 2019-2021 | |
| Boston Scientific Corporation | $115.00 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $105.23 | 2019-2021 | |
| Rxsight INC | $88.62 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $68.39 | 2019-2022 | |
| Biotissue Holdings INC. | $66.51 | 2022-2024 | |
| Nova Eye, INC. | $56.07 | 2025 | |
| Mallinckrodt Hospital Products INC. | $49.31 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $29.74 | 2022 | |
| Eyevance Pharmaceuticals LLC | $13.64 | 2019 | |
| Iridex Corporation | $3.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.